Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dexelvucitabine (RVT), a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 22,500 | |||
5 mg | 在庫あり | ¥ 57,000 | |||
10 mg | 在庫あり | ¥ 91,500 | |||
25 mg | 在庫あり | ¥ 152,500 | |||
50 mg | 在庫あり | ¥ 217,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 62,500 |
説明 | Dexelvucitabine (RVT), a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection. |
別名 | D-D-4FC, DPC-817, RVT, beta-D-D-4FC, DFC |
分子量 | 227.19 |
分子式 | C9H10FN3O3 |
CAS No. | 134379-77-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/ml (132.05 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dexelvucitabine 134379-77-4 Microbiology/Virology Reverse Transcriptase D-D-4FC b-D-D-4FC Inhibitor thymidine DPC 817 Human immunodeficiency virus d-d4FC β-D-D-4FC cytidine DPC-817 DPC817 M184V mutation RVT antiretroviral inhibit Reverset 2′-deoxycytidine viral polymerase HIV resistant viruse nucleoside reverse transcriptase beta-D-D-4FC HIV-1 DFC inhibitor